Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Soonchunhyang University Bucheon Hospital, |
RCV000490377 | SCV000267250 | likely benign | Complement factor b deficiency | 2016-03-18 | criteria provided, single submitter | reference population | |
Illumina Laboratory Services, |
RCV000397050 | SCV000462055 | likely benign | Atypical hemolytic-uremic syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000307542 | SCV000462056 | likely benign | Macular degeneration | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000405285 | SCV000484239 | likely benign | Complement component 2 deficiency | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000307542 | SCV000484240 | likely benign | Macular degeneration | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000438164 | SCV000510737 | benign | not provided | 2017-02-09 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000455606 | SCV000538664 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF 5.8% in South Asian chr in ExAC. |
Mendelics | RCV000405285 | SCV001137074 | benign | Complement component 2 deficiency | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001155246 | SCV001316665 | likely benign | Atypical hemolytic-uremic syndrome with B factor anomaly | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Invitae | RCV000438164 | SCV001721196 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000438164 | SCV001872577 | benign | not provided | 2021-03-22 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 20108004, 26911616, 33213850, 28939980, 28710236, 24652797, 30046676, 33238263, 27884173, 20513133) |
Genome Diagnostics Laboratory, |
RCV000397050 | SCV002587612 | benign | Atypical hemolytic-uremic syndrome | 2022-06-24 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002494551 | SCV002799349 | benign | Atypical hemolytic-uremic syndrome with B factor anomaly; Age related macular degeneration 14; Complement factor b deficiency | 2022-04-07 | criteria provided, single submitter | clinical testing |